BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 26885792)

  • 1. Polypodium Leucotomos--An Overview of Basic Investigative Findings.
    Berman B; Ellis C; Elmets C
    J Drugs Dermatol; 2016 Feb; 15(2):224-8. PubMed ID: 26885792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polypodium leucotomos extract: a status report on clinical efficacy and safety.
    Winkelmann RR; Del Rosso J; Rigel DS
    J Drugs Dermatol; 2015 Mar; 14(3):254-61. PubMed ID: 25738847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of oral Polypodium leucotomos extract in dermatologic diseases: a review of the literature.
    Choudhry SZ; Bhatia N; Ceilley R; Hougeir F; Lieberman R; Hamzavi I; Lim HW
    J Drugs Dermatol; 2014 Feb; 13(2):148-53. PubMed ID: 24509964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polypodium leucotomos extract in atopic dermatitis: a randomized, double-blind, placebo-controlled, multicenter trial.
    Ramírez-Bosca A; Zapater P; Betlloch I; Albero F; Martínez A; Díaz-Alperi J; Horga JF;
    Actas Dermosifiliogr; 2012 Sep; 103(7):599-607. PubMed ID: 22560125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polypodium leucotomos: a potential new photoprotective agent.
    Bhatia N
    Am J Clin Dermatol; 2015 Apr; 16(2):73-9. PubMed ID: 25666116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral administration of a hydrophilic extract of Polypodium leucotomos for the prevention of polymorphic light eruption.
    Tanew A; Radakovic S; Gonzalez S; Venturini M; Calzavara-Pinton P
    J Am Acad Dermatol; 2012 Jan; 66(1):58-62. PubMed ID: 21696853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subacute cutaneous lupus erythematosus: a case report of Polypodium leucotomos as an adjuvant therapy.
    Breithaupt AD; Jacob SE
    Cutis; 2012 Apr; 89(4):183-4. PubMed ID: 22611747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Oral Polypodium Leucotomos Extract in Chronic Photoinduced Hypersensitivity Dermatitis.
    Luber AJ; Calame A; Jacob SE
    Skinmed; 2016; 14(1):62-3. PubMed ID: 27072735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polypodium leucotomos as an Adjunct Treatment of Pigmentary Disorders.
    Nestor M; Bucay V; Callender V; Cohen JL; Sadick N; Waldorf H
    J Clin Aesthet Dermatol; 2014 Mar; 7(3):13-7. PubMed ID: 24688621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of vitiligo vulgaris with narrow-band UVB and oral Polypodium leucotomos extract: a randomized double-blind placebo-controlled study.
    Middelkamp-Hup MA; Bos JD; Rius-Diaz F; Gonzalez S; Westerhof W
    J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):942-50. PubMed ID: 17659004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polypodium leucotomos extract: a nutraceutical with photoprotective properties.
    Gonzalez S; Alonso-Lebrero JL; Del Rio R; Jaen P
    Drugs Today (Barc); 2007 Jul; 43(7):475-85. PubMed ID: 17728848
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Cyr P; Richer V
    J Cutan Med Surg; 2021; 25(6):656-657. PubMed ID: 34130522
    [No Abstract]   [Full Text] [Related]  

  • 13. Dermatologic Applications of
    Segars K; McCarver V; Miller RA
    J Clin Aesthet Dermatol; 2021 Feb; 14(2):50-60. PubMed ID: 34221229
    [No Abstract]   [Full Text] [Related]  

  • 14. Sun protection in a pill: the photoprotective properties of Polypodium leucotomos extract.
    El-Haj N; Goldstein N
    Int J Dermatol; 2015 Mar; 54(3):362-6. PubMed ID: 25040452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial regulation of matrixmetalloproteinases and their inhibitors, fibrillar collagens and transforming growth factor-beta by Polypodium leucotomos, directly or in dermal fibroblasts, ultraviolet radiated fibroblasts, and melanoma cells.
    Philips N; Conte J; Chen YJ; Natrajan P; Taw M; Keller T; Givant J; Tuason M; Dulaj L; Leonardi D; Gonzalez S
    Arch Dermatol Res; 2009 Aug; 301(7):487-95. PubMed ID: 19373483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential effect of Polypodium leucotomos extract on ultraviolet- and visible light-induced photoaging.
    Pourang A; Dourra M; Ezekwe N; Kohli I; Hamzavi I; Lim HW
    Photochem Photobiol Sci; 2021 Sep; 20(9):1229-1238. PubMed ID: 34449075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of oral Polypodium leucotomos extract on ultraviolet B response: A human clinical study.
    Kohli I; Shafi R; Isedeh P; Griffith JL; Al-Jamal MS; Silpa-Archa N; Jackson B; Athar M; Kollias N; Elmets CA; Lim HW; Hamzavi IH
    J Am Acad Dermatol; 2017 Jul; 77(1):33-41.e1. PubMed ID: 28341348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral Polypodium leucotomos extract decreases ultraviolet-induced damage of human skin.
    Middelkamp-Hup MA; Pathak MA; Parrado C; Goukassian D; Rius-Díaz F; Mihm MC; Fitzpatrick TB; González S
    J Am Acad Dermatol; 2004 Dec; 51(6):910-8. PubMed ID: 15583582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effects of Polypodium leucotomos extract against UVB-induced damage in a model of reconstructed human epidermis.
    Torricelli P; Fini M; Fanti PA; Dika E; Milani M
    Photodermatol Photoimmunol Photomed; 2017 May; 33(3):156-163. PubMed ID: 28140474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral administration of Polypodium leucotomos delays skin tumor development and increases epidermal p53 expression and the anti-oxidant status of UV-irradiated hairless mice.
    Rodríguez-Yanes E; Cuevas J; González S; Mallol J
    Exp Dermatol; 2014 Jul; 23(7):526-8. PubMed ID: 24862559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.